Better survival is observed in cervical cancer patients positive for specific anti-glycan antibodies and receiving brachytherapy

OBJECTIVE: To measure anti-glycan antibodies (AGA) in cervical cancer (CC) patient sera and assess their effect on therapeutic outcome. PATIENTS AND METHODS: Serum AGA was measured in 276 stage II and 292 stage III Peruvian CC patients using a high content and throughput Luminex multiplex glycan arr...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Gynecol Oncol
Glavni autori: Purohit, Sharad, Ferris, Daron G, Alvarez, Manual, Tran, Paul MH, Tran, Lynn KH, Mysona, David P, Hopkins, Diane, Zhi, Wenbo, Dun, Boying, Wallbillich, John J, Cummings, Richard D., Wang, Peng George, She, Jin-Xiong
Format: Artigo
Jezik:Inglês
Izdano: 2020
Teme:
Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8176459/
https://ncbi.nlm.nih.gov/pubmed/31955861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2020.01.014
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items